WOLVERINE TRADING, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2022$175,000
-81.4%
12,100
-79.1%
0.00%
Q3 2021$942,000
-42.2%
57,776
-40.3%
0.00%
-100.0%
Q2 2021$1,629,000
-65.6%
96,776
-62.5%
0.00%
-57.1%
Q1 2021$4,733,000
+132.7%
257,923
+130.6%
0.01%
+133.3%
Q4 2020$2,034,000
+140.7%
111,848
+140.0%
0.00%
+50.0%
Q3 2020$845,000
-30.8%
46,600
-30.9%
0.00%
-50.0%
Q2 2020$1,221,000
+15.5%
67,400
-0.3%
0.00%
+33.3%
Q1 2020$1,057,000
-14.6%
67,600
-3.3%
0.00%
-25.0%
Q2 2019$1,237,000
+91.2%
69,900
+119.8%
0.00%
+100.0%
Q1 2019$647,00031,8000.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2022
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders